I. Reduce the rate of bacterobilia driven surgical site infection (SSI) in patients undergoing pancreatic head resection by providing surgical team with nanopore sequencing (NS) data in the post-operative setting.
II. Reduce cost of care through reduction in SSI and improved antibiotic stewardship.
OUTLINE: Patients are randomized to 1 of 2 arms.
ARM I: Patients undergo the collection of bile samples during standard of care surgery. Samples undergo routine laboratory testing.
ARM II: Patients undergo the collection of bile samples during standard of care surgery. Samples undergo nanopore sequencing and routine laboratory testing.
After completion of study, patients’ medical records are reviewed for 30 days.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.